Race and ethnicity are associated with delays or discontinuations of cancer treatment after COVID-19, but social determinants of health are not, a study suggests.
Race and ethnicity, area-level social determinants of health linked to delayed or discontinued cancer treatment
Reduction seen in mortality with COVID-19 convalescent plasma transfusion in randomized clinical trials, matched cohort studies
Female sex and high BMI associated with an increased risk for post-COVID-19 syndrome
Gout patients are susceptible to breakthrough COVID-19 infection and severe outcomes despite vaccination.
Risk for severe outcomes of COVID-19 higher for patients with hematologic versus solid cancer
No association seen with death, major adverse cardiovascular events, rehospitalization following elective major noncardiac surgery
Female sex and previous mental health disorders, asthma associated with long COVID, regardless of COVID-19 severity
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality
